BerGenBio ASA (0RU5.L)
NOK 1.71
(-3.82%)
NOK 1.71
(-3.82%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - NOK | -100.0% |
| 2022 | 275 Thousand NOK | -70.81% |
| 2021 | 942 Thousand NOK | -31.09% |
| 2020 | 1.36 Million NOK | 0.0% |
| 2019 | - NOK | 0.0% |
| 2018 | - NOK | -100.0% |
| 2017 | 20.34 Million NOK | 12.84% |
| 2016 | 18.02 Million NOK | 1510.9% |
| 2015 | 1.11 Million NOK | 0.0% |
| 2014 | - NOK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - NOK | 0.0% |
| 2024 Q1 | - NOK | 0.0% |
| 2023 Q2 | - NOK | -100.0% |
| 2023 Q1 | 650 Thousand NOK | 136.36% |
| 2023 FY | - NOK | -100.0% |
| 2023 Q4 | - NOK | -100.0% |
| 2023 Q3 | 101 Thousand NOK | 0.0% |
| 2022 Q1 | 796 Thousand NOK | -15.5% |
| 2022 Q4 | 275 Thousand NOK | 0.0% |
| 2022 FY | 275 Thousand NOK | -70.81% |
| 2022 Q3 | - NOK | -100.0% |
| 2022 Q2 | 651 Thousand NOK | -18.22% |
| 2021 Q4 | 942 Thousand NOK | -7.28% |
| 2021 FY | 942 Thousand NOK | -31.09% |
| 2021 Q2 | 1.24 Million NOK | -5.27% |
| 2021 Q3 | 1.01 Million NOK | -18.06% |
| 2021 Q1 | 1.3 Million NOK | -4.24% |
| 2020 Q2 | - NOK | 0.0% |
| 2020 FY | 1.36 Million NOK | 0.0% |
| 2020 Q1 | - NOK | 0.0% |
| 2020 Q3 | - NOK | 0.0% |
| 2020 Q4 | 1.36 Million NOK | 0.0% |
| 2019 Q3 | 63 Thousand NOK | -74.6% |
| 2019 Q2 | 248 Thousand NOK | -19.22% |
| 2019 Q1 | 307 Thousand NOK | 0.0% |
| 2019 FY | - NOK | 0.0% |
| 2019 Q4 | - NOK | -100.0% |
| 2018 Q1 | - NOK | 0.0% |
| 2018 FY | - NOK | -100.0% |
| 2018 Q4 | - NOK | 0.0% |
| 2018 Q3 | - NOK | 0.0% |
| 2018 Q2 | - NOK | 0.0% |
| 2017 Q4 | - NOK | 0.0% |
| 2017 FY | 20.34 Million NOK | 12.84% |
| 2017 Q2 | - NOK | 0.0% |
| 2017 Q3 | - NOK | 0.0% |
| 2016 Q4 | - NOK | 0.0% |
| 2016 FY | 18.02 Million NOK | 1510.9% |
| 2015 FY | 1.11 Million NOK | 0.0% |
| 2014 FY | - NOK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Photocure ASA | 13.97 Million NOK | 100.0% |